160 related articles for article (PubMed ID: 22920876)
1. [Could antifungal lock be useful in the management of candidiasis linked with catheters?].
Cateau E; Rodier MH; Imbert C
Med Sci (Paris); 2012; 28(8-9):740-5. PubMed ID: 22920876
[TBL] [Abstract][Full Text] [Related]
2. Development of New Strategies for Echinocandins: Progress in Translational Research.
Walsh TJ; Azie N; Andes DR
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S601-3. PubMed ID: 26567276
[TBL] [Abstract][Full Text] [Related]
3. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
4. Antifungal lock therapy with combined 70% ethanol and micafungin in a critically ill infant.
Piersigilli F; Auriti C; Bersani I; Goffredo B; Bianco G; Savarese I; Dotta A
Pediatr Infect Dis J; 2014 Apr; 33(4):419-20. PubMed ID: 24637514
[TBL] [Abstract][Full Text] [Related]
5. In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species.
Öncü S
J Infect Chemother; 2011 Oct; 17(5):634-9. PubMed ID: 21327934
[TBL] [Abstract][Full Text] [Related]
6. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.
Basas J; Morer A; Ratia C; Martín MT; Del Pozo JL; Gomis X; Rojo-Molinero E; Torrents E; Almirante B; Gavaldà J
J Antimicrob Chemother; 2016 Oct; 71(10):2895-901. PubMed ID: 27378814
[TBL] [Abstract][Full Text] [Related]
8. [Activity of micafungin against Candida biofilms].
Quindós G; Villar-Vidal M; Eraso E
Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
[TBL] [Abstract][Full Text] [Related]
9. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
Toulet D; Debarre C; Imbert C
J Antimicrob Chemother; 2012 Feb; 67(2):430-2. PubMed ID: 22081268
[TBL] [Abstract][Full Text] [Related]
10. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
12. Persistent Candida conglobata bloodstream infection in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Khan S; Khan Z; Joseph L; Vayalil S; Chandy R
J Mycol Med; 2017 Jun; 27(2):271-276. PubMed ID: 28189376
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin.
Hagiya H; Kajioka H
Intern Med; 2013; 52(18):2139-43. PubMed ID: 24042529
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.
Basas J; Palau M; Gomis X; Almirante B; Gavaldà J
PLoS One; 2019; 14(2):e0212426. PubMed ID: 30779771
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the effectiveness and dose of micafungin in the treatment of candidemia].
Sugawara T; Murakami N; Uetake N; Matsumoto S; Miyamori S; Okamoto R; Hiraki K
Yakugaku Zasshi; 2014; 134(3):433-8. PubMed ID: 24584025
[TBL] [Abstract][Full Text] [Related]
16. Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia.
Tascini C; Sozio E; Di Paolo A; Tintori G; Leonildi A; Bertolino G; Carmassi F; Tagliaferri E; Menichetti F; Barchiesi F
J Chemother; 2017 Dec; 29(6):376-379. PubMed ID: 28198656
[TBL] [Abstract][Full Text] [Related]
17. Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates.
Castagnola E; Franceschi A; Natalizia AR; Mantero E; Tuo P
J Chemother; 2009 Apr; 21(2):234-5. PubMed ID: 19423483
[No Abstract] [Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
20. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
